Literature DB >> 10830883

Redox reactions of neurotransmitters possibly involved in the progression of Parkinson's Disease.

W Linert1, G N Jameson.   

Abstract

In Parkinson's Disease the neuromelanin in the substania nigra is known to contain considerably increased amounts of iron suggesting the presence of free, unprotected iron ions during its formation. Iron(II) is known to interact with peroxide via Fenton's reaction producing OH-radicals or ferryl (Fe(IV)) species. This can readily oxidize the neurotransmitter dopamine to the neurotoxic 6-hydroxydopamine (6-OHDA) which is a strong reducing agent. The produced 6-OHDA is, in turn, able to reduce and possibly release iron, as iron(II), from the iron storage protein ferritin. This cycle of events could well explain the development of Parkinson's Disease due to a continuous production of cell damaging species. The contrasting behaviour of 6-OHDA with some other important catecholamines is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10830883     DOI: 10.1016/s0162-0134(99)00238-x

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  18 in total

1.  Ethnic difference in the relationship between acute inflammation and serum ferritin in US adult males.

Authors:  Y Pan; R T Jackson
Journal:  Epidemiol Infect       Date:  2007-03-22       Impact factor: 2.451

2.  Knockout fth1b affects early mineralization of zebrafish pharyngeal teeth.

Authors:  Chun-Yan Zhou; Xue-Dan Zheng; De-Qin Yang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-02-01

3.  Intranigral dopamine toxicity and alpha-synuclein response in rats.

Authors:  Cristina Gómez-Santos; Pol Giménez-Xavier; Isidre Ferrer; Santiago Ambrosio
Journal:  Neurochem Res       Date:  2006-06-28       Impact factor: 3.996

4.  The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease.

Authors:  Mrudang Shah; Subramanian Rajagopalan; Liping Xu; Chandrashekhar Voshavar; Yevgeniya Shurubor; Flint Beal; Julie K Andersen; Aloke K Dutta
Journal:  J Neurochem       Date:  2014-06-21       Impact factor: 5.372

5.  Different mechanisms between copper and iron in catecholamines-mediated oxidative DNA damage and disruption of gene expression in vitro.

Authors:  Yoshihiko Nishino; Motozumi Ando; Rena Makino; Koji Ueda; Yoshinori Okamoto; Nakao Kojima
Journal:  Neurotox Res       Date:  2010-10-30       Impact factor: 3.911

Review 6.  Nuclear transport, oxidative stress, and neurodegeneration.

Authors:  Vivek P Patel; Charleen T Chu
Journal:  Int J Clin Exp Pathol       Date:  2011-02-28

7.  Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers.

Authors:  Ismael Santa-María; Félix Hernández; Mark A Smith; George Perry; Jesús Avila; Francisco J Moreno
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

8.  D-512 and D-440 as novel multifunctional dopamine agonists: characterization of neuroprotection properties and evaluation of in vivo efficacy in a Parkinson's disease animal model.

Authors:  Soumava Santra; Liping Xu; Mrudang Shah; Mark Johnson; Aloke Dutta
Journal:  ACS Chem Neurosci       Date:  2013-08-20       Impact factor: 4.418

9.  Reactivity of catecholamine-driven Fenton reaction and its relationships with iron(III) speciation.

Authors:  Victoria Melin; Adolfo Henríquez; Juanita Freer; David Contreras
Journal:  Redox Rep       Date:  2014-12-12       Impact factor: 4.412

10.  Altered transcription factor trafficking in oxidatively-stressed neuronal cells.

Authors:  Vivek P Patel; Donald B Defranco; Charleen T Chu
Journal:  Biochim Biophys Acta       Date:  2012-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.